Journal
SCIENTIFIC REPORTS
Volume 7, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/srep44123
Keywords
-
Categories
Funding
- NIH [P01-CA080124, R01-CA159258, R21-CA139168, R35 CA197743]
- Proton Beam/Federal Share Program
- American Cancer Society [120733-RSG-11-073-01-TBG]
- Ministry of Science and Technology [103-2221-E-007-032-MY2, 104-2628-B-007-001-MY3]
- Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grant [104N2744E1]
- Norway-Romania joint project [4SEE P4/30.06.2014]
Ask authors/readers for more resources
Sorafenib is a RAF inhibitor approved for several cancers, including hepatocellular carcinoma (HCC). Inhibition of RAF kinases can induce a dose-dependent paradoxical upregulation of the downstream mitogen-activated protein kinase (MAPK) pathway in cancer cells. It is unknown whether paradoxical ERK activation occurs after sorafenib therapy in HCC, and if so, if it impacts the therapeutic efficacy. Here, we demonstrate that RAF inhibition by sorafenib rapidly leads to RAF dimerization and ERK activation in HCCs, which contributes to treatment evasion. The transactivation of RAF dimers and ERK signaling promotes HCC cell survival, prevents apoptosis via downregulation of BIM and achieves immunosuppression by MAPK/NF-kB-dependent activation of PD-L1 gene expression. To overcome treatment evasion and reduce systemic effects, we developed CXCR4-targeted nanoparticles to co-deliver sorafenib with the MEK inhibitor AZD6244 in HCC. Using this approach, we preferentially and efficiently inactivated RAF/ERK, upregulated BIM and down-regulated PD-L1 expression in HCC, and facilitated intra-tumoral infiltration of cytotoxic CD8+ T cells. These effects resulted in a profound delay in tumor growth. Thus, this nano-delivery strategy to selectively target tumors and prevent the paradoxical ERK activation could increase the feasibility of dual RAF/MEK inhibition to overcome sorafenib treatment escape in HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available